Key result
PDK4 upregulation drives cardiac lymphatic endothelial remodeling in diabetic cardiomyopathy via impaired VEGF-C/VEGFR3 signaling.
Why the study?
Diabetic cardiomyopathy is characterized by microvascular dysfunction, but the role of cardiac lymphatic endothelial cells remains unknown.
This preclinical study identifies PDK4 upregulation and disrupted venous-lymphatic VEGF-C/VEGFR3 communication as key mechanisms of cardiac lymphatic endothelial cell dysfunction in diabetic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Suggests lymphatic endothelial remodeling as a novel target in diabetic cardiomyopathy; leaves open translation of PDK4/VEGF-C findings to human disease.
BACKGROUND: Diabetic cardiomyopathy (DCM) is characterized by microvascular dysfunction. While vascular endothelial cells (ECs) have been widely studied, the role of cardiac lymphatic ECs (LECs) in DCM remains unknown. METHODS: A mouse model of DCM was induced by a high-fat diet (HFD) with streptozotocin (STZ) injection. We performed single-cell RNA sequencing (scRNA-seq) on cardiac tissues from mice with DCM and control mice. We then applied clustering, RNA velocity, pseudotime analysis, and CellChat cell-cell communication analysis to define lymphatic endothelial cell (LEC) heterogeneity and underlying regulatory networks. RESULTS: Our analysis revealed profound pathological remodeling of the cardiac lymphatic architecture in diabetic hearts, marked by decreased LEC numbers and impaired function. Cell-cell communication analysis demonstrated impaired VEGF-C/VEGFR3 signaling between venous ECs (VECs) and LECs in diabetic hearts. We identified the upregulation of pyruvate dehydrogenase kinase 4 (PDK4) expression in diabetic LECs as a key driver of metabolic reprogramming, leading to impaired cell migration. CONCLUSIONS: This study mapped the profile of LECs in diabetic hearts and revealed a dual pathogenic mechanism involving metabolic disorders driven by PDK4 and disruption of venous-lymphatic communication. These findings may provide new strategies for the treatment of DCM.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied Diabetic cardiomyopathy (n=4). High-fat diet and streptozotocin vs. Standard laboratory diet and vehicle injection was evaluated on Single-cell transcriptomic profile of cardiac lymphatic endothelial cells. In a mouse model of diabetic cardiomyopathy, single-cell RNA sequencing revealed pathological remodeling of cardiac lymphatic endothelial cells driven by PDK4 upregulation and impaired VEGF-C/VEGFR3 signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: